** Shares of Cyclopharm up 17.2% at A$2.38
** Stock rises as much as 23.2% to A$2.5 in early trade, hitting its highest level since Oct 16, 2023
** Radiopharmaceutical firm signs contract with healthcare provider Hospital Corporation of America Healthcare $(HCA)$
** Says contract for deployment of co's Technegas imaging technology in up to 169 nuclear medicine departments across HCA'S network
** Co did not provide any transactional details regarding contract
** Technegas imaging technology is used to detect pulmonary embolism
** More than 502,000 shares change hands, 5.8 times the 30-day avg
** Cyclopahrm up 49.5% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。